Ibogaine by David Dardashti, a leading voice in the exploration of ibogaine's therapeutic potential, is closely analyzing a new study published in EMBO Reports that sheds light on the intricate ...

Get Instant Summarized Text (Gist) Advanced AI genetics models have been applied to Parkinson's disease, identifying genetic factors in its progression and potential FDA-approved drugs for repurposing ...

Scientists employ deep learning to analyze and compare gene regulation across various cell types in human and chicken brains.

From a study that analyzed brain images of more than 2,500 people with Parkinson's disease in 20 different countries, ...

Brandi Muhle was 9 years old when her 35-year-old mother, an Omaha police officer and a marathon runner, was first diagnosed ...

During the past decade, Parkinson disease (PD) has evolved from a textbook example of a mostly nonhereditary disease to a complex disorder with a well-established genetic component in a ...

The npj Parkinson's Disease report uses an approach called "systems biology," which uses AI to integrate and analyze multiple different forms of information from genetic, proteomic, pharmaceutical ...

Gene therapy represents a paradigm shift in modern medicine, offering unprecedented opportunities to combat diseases at their ...

A comprehensive analysis has identified novel enhancers associated with neuronal development and disease.

Researchers have successfully applied advanced artificial intelligence (AI) genetics models to Parkinson's disease. Researchers identified genetic factors in progression and FDA-approved drugs that ...

People with early-onset Parkinson’s face challenges different from those with traditional late-onset Parkinson’s.

The Google cofounder has donated more than $1.5 billion to Parkinson’s research. Now, as he takes on autism, he’s also ...